Chronic NSAID use may reduce risk of age-related cognitive decline -- NIA study.
This article was originally published in The Tan Sheet
Executive Summary
LONG-TERM NSAID USE LINKED TO REDUCED RISK OF ALZHEIMER'S DISEASE and other age-related causes of cognitive decline, according to a 7,671-subject prospective study that appears in the September issue of the Journal of the American Geriatrics Society. Researchers at the National Institute on Aging, led by Renzo Rozzini, MD, P. Richiedei Hospital, Italy, reported that cognitive function at the end of a three-year observation period "was significantly higher in chronic NSAID users than in controls."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning